Ls Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Ls Investment Advisors, LLC

$680 Million
Q3 2025

A detailed history of Ls Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ls Investment Advisors, LLC holds 17,565 shares of BMY stock, worth $822,217. This represents 0.12% of its overall portfolio holdings.

Number of Shares

17,565

Previous 22,365 21.46%

Holding current value

$822,217

Previous $1.04 Million 23.48%

% of portfolio

0.12%

Previous 0.16%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 22, 2025	SELL	$43.31 - $48.98 $207,888 - $235,103	-4,800 Reduced 21.46%	17,565 $792,000
Q2 2025 Jul 16, 2025	BUY	$44.12 - $59.6 $236,042 - $318,860	5,350 Added 31.44%	22,365 $1.04 Million
Q1 2025 Apr 10, 2025	BUY	$53.9 - $63.11 $12,127 - $14,199	225 Added 1.34%	17,015 $1.04 Million
Q4 2024 Jan 24, 2025	BUY	$51.92 - $59.94 $635,760 - $733,965	12,245 Added 269.42%	16,790 $949,000
Q3 2024 Oct 31, 2024	BUY	$39.66 - $51.75 $180,254 - $235,203	4,545 New	4,545 $235,000

Q1 2024 Apr 30, 2024	SELL	$47.98 - $54.4 $10,795 - $12,240	-225 Reduced 4.52%	4,750 $257,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $775,221 - $903,726	-14,455 Reduced 74.4%	4,975 $310,000
Q3 2021 Oct 21, 2021	SELL	$59.17 - $69.31 $2,899 - $3,396	-49 Reduced 0.25%	19,430 $1.15 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $4.5 Million - $4.9 Million	-72,732 Reduced 78.88%	19,479 $1.3 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $1.33 Million - $1.5 Million	-22,410 Reduced 19.55%	92,211 $5.82 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $243,720 - $276,180	-4,221 Reduced 3.55%	114,621 $7.11 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $181,363 - $200,975	3,158 Added 2.73%	118,842 $7.17 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $961,268 - $1.12 Million	17,535 Added 17.87%	115,684 $6.8 Million
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $392,404 - $570,255	-8,457 Reduced 7.93%	98,149 $5.47 Million
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $1.45 Million - $1.9 Million	29,556 Added 38.36%	106,606 $6.84 Million
Q3 2019 Oct 31, 2019	SELL	$42.77 - $50.71 $11,847 - $14,046	-277 Reduced 0.36%	77,050 $3.91 Million
Q2 2019 Aug 07, 2019	BUY	$44.62 - $49.34 $27,842 - $30,788	624 Added 0.81%	77,327 $3.51 Million
Q1 2019 Apr 25, 2019	BUY	$45.12 - $53.8 $38,036 - $45,353	843 Added 1.11%	76,703 $3.66 Million
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $640,170 - $830,146	-13,129 Reduced 14.75%	75,860 $3.94 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $80,135 - $90,387	-1,452 Reduced 1.61%	88,989 $5.52 Million
Q2 2018 Jul 20, 2018	BUY	$50.53 - $62.98 $212,226 - $264,516	4,200 Added 4.87%	90,441 $5.01 Million
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $479,659 - $552,184	-8,005 Reduced 8.49%	86,241 $5.46 Million
Q4 2017 Feb 07, 2018	BUY	$59.94 - $65.35 $247,552 - $269,895	4,130 Added 4.58%	94,246 $5.78 Million
Q3 2017 Oct 19, 2017	BUY	$55.23 - $63.74 $4.98 Million - $5.74 Million	90,116	90,116 $5.74 Million

Others Institutions Holding BMY

# of Institutions

2,709

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ls Investment Advisors, LLC with notifications on news.

Account

Ls Investment Advisors, LLC Bristol Myers Squibb CO Transaction History